Boxer Capital’s AnaptysBio ANAB Stock Holding History

Boxer Capital’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,300,000	Closed	-$43.5M	–	2
2024 Q3	$43.5M	Hold	1,300,000	–	–	2.14%	15
2024 Q2	$32.6M	Hold	1,300,000	–	–	1.72%	17
2024 Q1	$29.3M	Hold	1,300,000	–	–	1.45%	21
2023 Q4	$27.8M	Hold	1,300,000	–	–	1.39%	22
2023 Q3	$23.3M	Hold	1,300,000	–	–	1.24%	28
2023 Q2	$26.4M	Hold	1,300,000	–	–	1.23%	29
2023 Q1	$28.3M	Hold	1,300,000	–	–	1.39%	23
2022 Q4	$40.3M	Hold	1,300,000	–	–	2.12%	15
2022 Q3	$33.2M	Hold	1,300,000	–	–	1.87%	18
2022 Q2	$26.4M	Hold	1,300,000	–	–	1.67%	22
2022 Q1	$32.2M	Hold	1,300,000	–	–	1.65%	20
2021 Q4	$45.2M	Hold	1,300,000	–	–	1.75%	18
2021 Q3	$35.3M	Hold	1,300,000	–	–	1.23%	25
2021 Q2	$33.7M	Hold	1,300,000	–	–	1.19%	22
2021 Q1	$28M	Hold	1,300,000	–	–	0.95%	32
2020 Q4	$27.9M	Hold	1,300,000	–	–	0.9%	32
2020 Q3	$19.2M	Hold	1,300,000	–	–	0.66%	37
2020 Q2	$29M	Hold	1,300,000	–	–	1.28%	30
2020 Q1	$18.4M	Hold	1,300,000	–	–	1.25%	24
2019 Q4	$21.1M	Buy	+1,300,000	New	+$30.7M	1.19%	25
2017 Q2	–	Sell	-50,000	Closed	-$1.39M	–	31
2017 Q1	$1.39M	Buy	+50,000	New	+$1.16M	0.3%	26

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Boxer Capital's ANAB Position: Q4 2024 in Review

Boxer Capital sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 1,300,000 shares — an estimated $43.5M sold.

Boxer Capital first reported a position in ANAB in Q1 2017 and held it in 21 quarters. The position peaked at $45.2M in Q4 2021. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

Boxer Capital reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
Boxer Capital sold 1,300,000 AnaptysBio shares in Q4 2024, an estimated $43.5M.
Boxer Capital first reported a position in AnaptysBio in Q1 2017 and held it in 21 quarters.
Boxer Capital's AnaptysBio position peaked at $45.2M in Q4 2021.
135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.